Table 3.
Effects of D-allulose administration on fetal skeletal alterationsa.
Examination Indicators | Dose Groups (mg/kg bw) |
|||
---|---|---|---|---|
0 | 1250 | 2500 | 5000 | |
Skull | ||||
Skull osteolysis | 0/0b) | 0/0 | 0/0 | 0/0 |
Interparietal bone imperfect | 0/0 | 0/0 | 0/0 | 0/0 |
Interparietal bone deficiency | 0/0 | 0/0 | 0/0 | 0/0 |
Occipital bone imperfect | 0/0 | 0/0 | 0/0 | 0/0 |
Occipital bone deficiency | 0/0 | 0/0 | 0/0 | 0/0 |
Sternum | ||||
Sternum deficiency | 1/1 | 0/0 | 2/2 | 2/2 |
Sternum fusion | 0/0 | 0/0 | 0/0 | 0/0 |
Rib | ||||
Wavy rib | 0/0 | 0/0 | 0/0 | 0/0 |
Shortened rib | 0/0 | 0/0 | 0/0 | 0/0 |
Rib fracture | 0/0 | 0/0 | 0/0 | 0/0 |
Absence of rib | 0/0 | 0/0 | 0/0 | 0/0 |
Extra rib | 0/0 | 0/0 | 0/0 | 0/0 |
Phalanges | ||||
Oligodactyly | 0/0 | 0/0 | 0/0 | 0/0 |
No statistically significant differences were noted among the groups when analyzed by the Anova or Dunnett test.
Skeletal alterations were examined on 120, 150, 129, and 120 fetuses from 17, 20, 17, and 18 litters of the vehicle control, 1250, 2500, and 5000 mg/kg bw dose groups, respectively.
) Number of fetuses with the alteration /number of litters with the alteration.